MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202327067422 A) filed by Qgenetics Co. Ltd., Seoul, Republic of Korea, on Oct. 7, 2023, for 'sanguisorba officinalis linne extract composition inhibiting 3cl protease and rdrp activity of sars-cov-2.'
Inventor(s) include Chang, Mun Seog; Lee, Tae Hee; Lee, Min Ji; Lee, Seung Jae; Kim, Ha Young; Min, Jung Bin; Park, Ji Hye; Choi, Won Hyung; and Park, Wook Ha.
The application for the patent was published on March 7, under issue no. 10/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel use of a Sanguisorba officinalis Linne extract in inhibiting the 3CL protease and RdRp activity of SA...